Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Phillips-Medisize appoints Michael Ratigan VP Sales
Phillips-Medisize appoints Michael Ratigan VP Sales
Michael Ratigan has been appointed Vice President of Global Sales
Worldwide Clinical Trials founder honoured with European CEO award
Worldwide Clinical Trials founder honoured with European CEO award
Neal Cutler recognised as Best CEO in the CRO Industry for his leadership in pivotal clinical trials and success as a clinical researcher
BioreclamationIVT appoints Senior Marketing Communications Manager
BioreclamationIVT appoints Senior Marketing Communications Manager
Pharmalink appoints new Chief Executive Officer
Pharmalink appoints new Chief Executive Officer
Lauren P. Silvernail appointed to Nicox Board of Directors
Lauren P. Silvernail appointed to Nicox Board of Directors
Renewal of the terms of office of Birgit Stattin Norinder and Michele Garufi
Elligo Health names CDISC founder as new Scientific Innovation Officer
Elligo Health names CDISC founder as new Scientific Innovation Officer
New Chair of BCAS low pressure and vacuum group
New Chair of BCAS low pressure and vacuum group
Gardner Denver representative appointed to British Compressed Air Society’s group
CellGenix appoints leading experts to Scientific Advisory Board
CellGenix appoints leading experts to Scientific Advisory Board
Cliona Rooney, Mitchell H. Finer and Anthony Davies
Certara appoints Sandy Allerheiligen as Senior VP of Health Economics and Education
Certara appoints Sandy Allerheiligen as Senior VP of Health Economics and Education
Allerheiligen will use her model-informed drug development expertise to support Certara’s work in quantifying a drug’s value to patients
Cerecor appoints Steven Boyd and Peter Greenleaf to Board of Directors
Cerecor appoints Steven Boyd and Peter Greenleaf to Board of Directors
GW Pharmaceuticals R&D Management appointments
GW Pharmaceuticals R&D Management appointments
Volker Knappertz appointed Chief Medical Officer and Professor Ben Whalley to join as Head of Discovery Research
Abbas Hussain joins the Board of Immunocore as Non-Executive Director
Abbas Hussain joins the Board of Immunocore as Non-Executive Director
Ian Clark also appointed as special adviser to the Board
Macrophage Pharma appoints Development Director
Macrophage Pharma appoints Development Director
Joanne Bedwell-Garner joins management team
Biocartis announces its new CEO
Biocartis announces its new CEO
WIRB-Copernicus Group acquires MedAvante and ProPhase
WIRB-Copernicus Group acquires MedAvante and ProPhase
Names Jeffrey Litwin as the Chief Executive Officer (CEO) of the combined company
Chiesi USA makes two key leadership appointments
Chiesi USA makes two key leadership appointments
Doug Baratta and Donna White promoted to Vice President
Previous
1
…
77
78
79
80
(current)
81
82
83
…
216
Next
Trending Articles
Gerresheimer names new Chairman of the Supervisory Board
This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe
Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer
Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach
Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer
Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
Hovione appoints Stefan Doboczky as Chief Executive Officer
Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all